HY-157437
IC50 hAChE 30.35 +/- 2.07 nM; hBChE 48.03 +/- 6.41 nM
General
Type : Carbamate, Derivative of Tacrine, Alkyl linked bis-ligand, Derivative of Rivastigmine
Chemical_Nomenclature : [4-(1H-pyrrolo[2,3-b]pyridin-2-yl)phenyl] N-[6-[(6-fluoro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl]carbamate
Canonical SMILES : C1CCC2=NC3=C(C=CC(=C3)F)C(=C2C1)NCCCCCCNC(=O)OC4=CC=C(C=C4)C5=CC6=C(N5)N=CC=C6
InChI : InChI=1S\/C33H34FN5O2\/c34-24-13-16-27-30(21-24)38-28-10-4-3-9-26(28)31(27)35-17-5-1-2-6-18-37-33(40)41-25-14-11-22(12-15-25)29-20-23-8-7-19-36-32(23)39-29\/h7-8,11-16,19-21H,1-6,9-10,17-18H2,(H,35,38)(H,36,39)(H,37,40)
InChIKey : ZMLLZOVFQZLICZ-UHFFFAOYSA-N
Other name(s) : AChE\/BChE-IN-16 || CS-0926843 || -(1H-pyrrolo [2,3-b]pyridin-2-yl)phenyl (6-((6-fluoro-1,2,3,4-tetrahydroa cridin-9-yl)amino)hexyl)carbamate || Compound C7
MW : 551.7
Formula : C33H34FN5O2
CAS_number :
PubChem : 170453148
UniChem : ZMLLZOVFQZLICZ-UHFFFAOYSA-N
Target
Families : HY-157437 ligand of proteins in family
ACHE
BCHE
Protein :
human-ACHE
human-BCHE
References (1)
| Title : Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of Alzheimer's disease - Liu_2023_Eur.J.Med.Chem_265_116071 |
| Author(s) : Liu Y , Ma C , Li Y , Li M , Cui T , Zhao X , Li Z , Jia H , Wang H , Xiu X , Hu D , Zhang R , Wang N , Liu P , Yang H , Cheng M |
| Ref : Eur Journal of Medicinal Chemistry , 265 :116071 , 2023 |
| Abstract : |
| PubMedSearch : Liu_2023_Eur.J.Med.Chem_265_116071 |
| PubMedID: 38157596 |